Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis

Canadian Journal of Gastroenterology

Volumn 23, Issue 4, 2009, Pages 273-278

  Lonardo, Amedco ^a,c   Ballestri, Stefano ^a   Adinolfi, Luigi E ^b   Violi, Enrico ^a   Carulli, Lucia ^a   Lombardini, Silvia ^a   Scaglioni, Federica ^a   Ricchi, Matteo ^a   Ruggiero, Giuseppe ^a   Loria, Paola ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Nuovo Ospedale S Agostino   (Italy)

Author keywords

Body mass index; Fibrosis; HCV; HOMAR IR; Insulin resistance; Metabolic syndrome; Nonalcoholic fatty liver disease; Sex steatosis; Triglycerides

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENDER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL;

EID: 65649147917     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/369703     Document Type: Article

References (33)

1. Kotronen A, Westerbacka J, Bergholm R, Pietiläinen KH, Yki-Järvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 2007;92:3490-7.
2. Ratziu V, Heurtier A, Bonyhay L, Poynard T, Giral P. Review article: An unexpected virus-host interaction - the hepatitis C virus-diabetes link. Aliment Pharmacol Ther. 2005;22(Suppl 2):56-60.
3. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004;126:586-97.
4. Friis-Liby I, Aldenborg F, Jerlstad P, Rundstrom K, Bjornsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2004;39:864-9.
5. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45:846-54.
6. Adams LA, Lymp JF, St Sauver J, et al. The natural historv of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005;129:113-21.
7. Lonardo A, Carulli N, Loria P. HCV and diabetes. A two-question-based reappraisal. Dig Liver Dis 2007;39:753-61.
8. Lonardo A, Lombardini S, Scaglioni F, et al. Hepatic steatosis and insulin resistance: Does etiology make a difference? J Hepatol 2006;44:190-6.
9. Bugianesi E, Marchesini G, Gentilcore E, et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Hepatology 2006;44:1648-55.
10. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007;46:1126-32.
11. Svegliati-Baroni G, Bugianesi E, Bouserhal T, et al. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut 2007;56:1296-301.
12. Tsochatzis E, Patheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2008;27:80-9.
13. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-64.
14. Adinolfi LE. Hepatitis C and fatty liver. In: Negro F, ed. Hot Topics in Viral Hepatitis, Hepatitis C and Metabolism, 2nd edn. Modena: FB Communication, 2006:21-9.
15. Balkau B, Charles MA. Comments on the provisional report from the WHO consultation. Diabet Med 1999;16:442-3.
16. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:E462-8.
17. Lonardo A, Loria P, Leonardi F, et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 2002;34:204-11.
18. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
19. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
20. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
21. Scheuer PJ. Scoring of liver biopsies: Are we doing it right? Eur J Gastroenterol Hepatol 1996;8:1141-3.
22. Lonardo A, Loria P. The hepatitis C virus-associated dysmetabolic syndrome. Hepatology 2008;48:1018-9.
23. Farrell GC, Latter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006;43(2 Suppl 1):S99-S112.
24. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008;134:416-23.
25. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005;54:1003-8.
26. Vidali M, Tripodi M-F, Ivaldi A, et al. Interplay between oxidative stress and hepatic steatosis in the pathogenesis of chronic hepatitis C. J Hepatol 2008;48:399-406.
27. Yoneda M, Saito S, Ikeda T, et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondibaetic patients. J Viral Hepat 2007;14:600-7.
28. Hsu CS, Liu CJ, Liu CH, et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008;28:271-7.
29. Adinolfi LE, Utili R, Andreana A, et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci 2001;46:1677-83.
30. Lonardo A, Carani C, Carulli N, Loria P. Endocrine NAFLD' a hormonocentric perspertive of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006;44:1196-207.
31. Poynard T, Cacoub P, Ratzui V, et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002;9:295-303.
32. Cammà C, Bruno S, Di Marco V, et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 2006;43:64-71.
33. Codes L, Asselah T, Cazals-Hatem D, et al. Liver fibrosis in women with chronic hepatitis C: Evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut 2007;56:390-5.